Statistics
Publications
9
Citations
474
H-Index
9
Active since
2009
Xue Liang is an author at Chinese University of Hong Kong specializing in medicine, covid-19, and pharmacology.
Publications per year
2009–2024
9
9
Low dose ruxolitinib plus HLH-94 protocol: A potential choice for secondary HLH
Han Wang, Jia Gu, Xue Liang et al. · Seminars in Hematology · 2019 · 38 citations · Full text
Mitochondria-Targeted Antioxidant Peptide SS31 Protects the Retinas of Diabetic Rats
Junting Huang, X. Li, M. Li et al. · Current Molecular Medicine · 2013 · 37 citations
Zian Lin, Siyu Chen, Lixian Su et al. · BMC Medicine · 2024 · 18 citations · Full text
1–5 of 9